XSHE
300596
Market cap1.36bUSD
Oct 09, Last price
40.63CNY
1D
2.19%
1Q
-10.33%
IPO
240.57%
Name
Rianlon Corp
Chart & performance
P/E
18.79
P/S
1.55
EPS
2.16
Div yield, %
0.93%
Shrs. gr., 5y
2.29%
Rev. gr., 5y
19.39%
Revenues
6.02b
+5.91%
Net income
497m
+16.48%
CFO
378m
-18.42%
Dividend
Jun 18, 20260.45 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Globally, Rianlon Corporation offers specialized solutions for the polymeric materials sector, focusing on anti-aging additives and associated application technologies. Their comprehensive product line includes primary and secondary antioxidants, UV absorbers, and hindered amine light stabilizers (HALS). Additionally, they provide the 'Antioxidant U-pack,' a bespoke blending formulation engineered to deliver tailored anti-aging solutions. These additives are crucial for extending the lifespan and performance of materials used in diverse sectors such as automotive components, protective coatings, construction materials, packaging, electronics, and various household goods. Established in 1994, Rianlon Corporation maintains its headquarters in Tianjin, China.
Key people
Haiping Li
Chairman of the Board, President · since 2022
Wenjia Yan
Chief Financial Officer · since 2023
Borui Han
Vice President, Director · since 2022
Chunguang Sun
Vice President · since 2025
Changwu Xiong
Vice President · since 2025
Hongyan Bi
Director
Huan Ding
Staff Elected Director · since 2025
Xiaopeng Fan
Director · since 2025
Jintao Xie
Vice President, Secretary of the Board, Director · since 2023
Cuiling Feng
Independent Director · since 2025
Yongjun He
Independent Director · since 2019
Weiman Hou
Independent Director
Hongmei Li
Independent Director
Xueming Zeng
Independent Director · since 2025
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||